Key Takeaways
- ⭐ In the US government's 2027 quality ratings, 95% of Humana's Medicare Advantage members are now in plans rated 4 stars or higher. A year ago it was about 20%.
- 📈 Humana's shares closed up 11.56% at $431.87 on Friday. They had been up as much as 15–16% before the opening bell.
- 💵 Stars matter because plans rated 4 stars or higher earn bonus payments from the government. Evercore ISI estimates Humana could receive up to $4.8 billion in bonuses in 2028.
- 🏆 Humana's largest plan contract climbed back to 4 stars from 3.5. Analysts saw that as the single most important result.
- ⚖️ Honest catch: the money doesn't arrive until 2028, and Humana itself says part of the boost is one-time.
- 🔍 Want to dig deeper? Research Humana (HUM) and other healthcare names on Nemo.money, from $1.
The Short Version
Every October, the US government grades private Medicare plans. The scale runs from 1 to 5 stars.
For Humana, these grades are a big deal. It's one of the biggest providers of Medicare Advantage, private health plans for Americans aged 65 and over.
For two years, Humana's grades were poor. This year, they bounced back hard.
The stock jumped nearly 12% in a day. Here's why Medicare's star ratings are worth billions.
People are searching:
- Why did Humana stock go up?
- Humana star ratings 2027
- What are Medicare star ratings?
- Is Humana stock a good buy?
- Medicare Advantage star ratings bonus payments
⭐ What Happened
The government agency that runs Medicare (CMS) released its 2027 star ratings on Thursday 8 October.
Here's what Humana reported the next day:
- 🎯 95% of its Medicare Advantage members are in plans rated 4 stars or higher.
- 🌟 42% are in plans rated 4.5 stars.
- 📋 It has 6 contracts at 4.5 stars and 12 at 4 stars. That's 11 more contracts at 4 stars or higher than last year.
- 🏆 Its biggest contract (H5216) climbed back to 4 stars from 3.5. Barclays says this contract covers about 2.4 million people.
J.P. Morgan had expected Humana to land at 60–70%. Humana beat that by a wide margin.
📉📈 A Big Fall, Then a Big Comeback
This is a turnaround story. According to Healthcare Dive's analysis:
- ✅ A few years ago, about 94% of Humana's members were in 4-star-or-higher plans.
- ⬇️ That fell to about 25% for 2025, then about 20% for 2026.
- ⬆️ Now it's back to 95% for 2027. (Healthcare Dive's own count is 93%.)
Humana even went to court over how its 2025 ratings were worked out. It lost that case in October 2025, according to Reuters.
💵 Why Stars Mean Money
- 🎁 Plans rated 4 stars or higher get bonus payments from the government.
- 💰 They also keep a bigger share of the money left over when they bid below the government's benchmark. They can use it for extra benefits, which helps them win customers.
- 📅 The 2027 ratings decide the bonuses paid in 2028.
How much could that be worth? Analysts differ:
- Evercore ISI (Elizabeth Anderson): up to $4.8 billion in bonus payments in 2028.
- TD Cowen (Ryan Langston): $3 billion or more in extra 2028 revenue.
🔄 Winners and Losers
Not every insurer had a good day:
- 📉 Alignment Healthcare (ALHC): the share of its members in 4-star-or-higher plans is set to drop to about 25% from 98%. Its shares fell more than 20%.
- ➖ UnitedHealth (UNH) and CVS Health (CVS): J.P. Morgan estimates they slipped to about 67% (from 81%) and 70% (from 84%).
- 📊 The average rating across the industry dipped to 3.99 from 4.01. Only 15 contracts earned the top 5 stars, down from 22.
Because the government made the grading tougher this year, Humana's jump stands out even more.
💡 The One Lesson: Know What Moves Your Stock
Some stocks move on sales. Some move on new products.
Humana moves on its Medicare star ratings.
- 🗓️ For Medicare insurers, star ratings are one of the biggest events of the year.
- 🔁 They also reset every year. A great result this October doesn't guarantee the next one.
- 🧭 Before you own any stock, ask: "What one event could move this stock 10% in a day?"
🏢 What Humana Said
In a filing with the US Securities and Exchange Commission (SEC) on Friday, Humana said:
- ✅ It beat its goal of reaching the top 25% of its peers on star-related revenue.
- 📌 It reaffirmed its 2026 forecast of at least $9.00 in adjusted earnings per share.
- 🔂 It expects a 2028 benefit, partly one-time, to be used for one-time investments and returns to shareholders.
- 🗓️ It will give more detail at an investor update on 10 December 2026, with full 2028 numbers by its Q4 2027 results.
⚖️ The Honest Catch
Here's the case for caution:
- ⏳ It's a 2028 story. The extra money is more than a year away. A lot can change by then.
- 🔂 Part of it is one-time. Humana says so itself. Investors shouldn't treat it as permanent profit.
- 🎁 Some of the cash may be spent. Baird analysts note that the profit boost depends on how much Humana reinvests in member benefits and doctor payments.
- 🏛️ Policy risk. The government sets the rules, and it changed the grading this year. It could change them again.
- 💸 Some good news may be priced in. Barclays analyst Andrew Mok raised his target to $515 (Overweight) before the results, expecting the key contract to improve.
And here's the other side:
- 🚀 The turnaround is real. Going from about 20% to 95% in a single year is a huge swing.
- 🧱 Scale matters. Humana is one of the largest Medicare Advantage players, so the bonuses are big in dollar terms.
Both can be true. That's why it pays to do your own research.
🙋 What It Means for You
- 🧭 Don't chase a 12% jump. Big one-day moves can partly reverse.
- 📅 Know the dates: Medicare's sign-up period runs 15 October to 7 December, and Humana's investor update is 10 December.
- 🔍 Names to research: Humana (HUM), UnitedHealth (UNH) and CVS Health (CVS). Each is an example to research, not a recommendation.
- 🧺 Think about spread. One government decision moved this whole group of stocks in different directions. Our Top 10 Rules of Investing for Beginners explains why diversification matters.
- 🔁 Same lesson, different sector: TSMC booked record sales, but chip stocks still fell. And healthcare had another comeback on Friday: Moderna is back in the Nasdaq-100.
📱 How to Research with Nemo.money
- 💵 Start small. Invest from $1 with fractional shares.
- 0️⃣ Zero commission on trades.
- 💡 Not sure where to start? Try Nemes, themed ideas that help you find stocks to research.
- 🏦 Waiting for the dust to settle? You can keep cash in Nemo Wallet, earning 6% AER, paid daily in USD.
FAQs
1. Why did Humana stock go up? On 8 October, the US government released its 2027 Medicare Advantage star ratings. Humana said 95% of its members are now in plans rated 4 stars or higher, up from about 20% a year earlier. The shares closed up 11.56% on Friday 9 October.
2. What are Medicare star ratings? The US agency that runs Medicare (CMS) rates private Medicare plans from 1 to 5 stars every year. It looks at things like quality of care, customer service and drug plans. Plans rated 4 stars or higher get bonus payments.
3. How much money could the new ratings bring Humana? Analysts differ. Evercore ISI estimates up to $4.8 billion in bonus payments in 2028, while TD Cowen estimates $3 billion or more in extra 2028 revenue. Humana says part of the benefit will be one-time.
4. Is Humana stock a good buy right now? Supporters point to a sharp ratings turnaround, billions in possible 2028 bonuses and a reaffirmed 2026 forecast. Sceptics point to the long wait until 2028, the one-time element and the risk of government rule changes. HUM is an example to research, not a recommendation, and whether it suits you depends on your goals, timeframe and risk tolerance.
5. Can I invest in Humana from the UAE or India with a small amount? On Nemo.money you can invest in US-listed shares such as Humana (HUM) from $1 using fractional shares, with zero commission.
Final Thoughts
Humana has gone from poor Medicare ratings to strong ones in a single year. That's worth billions, and the market noticed.
But the reward arrives in 2028, part of it is one-time, and the grades reset every October.
Understand what moves the stock before you decide whether it belongs in your portfolio.
👉 Start researching on Nemo.money
Nemo = Never Miss Out.Stay informed. Stay ahead.
#Humana #HUM #HealthcareStocks #Medicare #StarRatings #StockMarket #InvestingUAE #NRIInvesting #NemoMoney #NeverMissOut
Terms and conditions apply. This is not investment advice. Past performance is not indicative of future results. Your capital is at risk. See website for Risk Disclosure. Exinity ME Ltd (nemo.money) is regulated by ADGM's Financial Services Regulatory Authority.
